Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA085-00-VP, in Healthy Adults

NCT02840487 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

NIH

Sponsor class

Conditions

Prevention of Zika Infection
Zika-Specific Immune Response

Interventions

BIOLOGICAL: VRC-ZKADNA085-00-VP

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)